Common antigenicity for two glycosidases

FEBS Letters

Volumn 580, Issue 1, 2006, Pages 87-92

  Kakavanos, Revecca ^a,b   Lehn, Pierre ^c   Callebaut, Isabelle ^d   Meikle, Peter J ^a,b   Parkinson Lawrence, Emma J ^a   Hopwood, John J ^a,b   Brooks, Doug A ^a,b  

^a Lysosomal Diseases Research Unit   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c BREST UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

Antibody cross reactivity; Antigenicity; Enzyme replacement therapy; Epitope reactivity; Glycosidase; Lysosomal storage disorders

Indexed keywords

ALPHA GLUCOSIDASE; EPITOPE; GLYCOSAMINOGLYCAN; GLYCOSIDASE; LEVO IDURONIDASE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGENICITY; ARTICLE; CROSS REACTION; ENZYME REPLACEMENT; GLYCOGEN STORAGE DISEASE TYPE 2; HURLER SYNDROME; IMMUNE RESPONSE; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ALPHA-GLUCOSIDASES; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; IDURONIDASE; LYSOSOMAL STORAGE DISEASES; MICE; MUCOPOLYSACCHARIDOSIS I;

ANIMALIA;

EID: 29344467700     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.11.053     Document Type: Article

References (28)

1. M.L. Sinnott Catalytic mechanisms of enzymic glycosyl transfer Chem. Rev. 90 1990 1171 1202
2. J.D. McCarter, and S.G. Withers Mechanisms of enzymatic glycoside hydrolysis Curr. Opin. Struct. Biol. 4 1994 885 892
3. B. Henrissat, and A. Bairoch Updating the sequence-based classification of glycosyl hydrolases Biochem. J. 316 1996 695 696
4. P. Durand, P. Lehn, I. Callebaut, S. Fabrega, B. Henrissat, and J.P. Mornon Active site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis Glycobiology 7 1997 277 284
5. P. Durand, S. Fabrega, B. Henrissat, J.P. Mornon, and P. Lehn Structural features of normal and mutant human lysosomal glycoside hydrolases deduced from bioinformatics analysis Hum. Mol. Genet. 9 2000 967 977
6. J. Jenkins, L. LoLeggio, G. Harris, and R. Pickersgill β-Glucosidase, β-galactosidase, family A cellulase, family F xylanases and two barley glycanases form a superfamily of enzymes with 8-fold β/α architecture and with two conserved glutamates near the carboxy-terminal ends of two β-strands four and seven FEBS Lett. 362 1995 281 285
7. D. Rigden Iterative database searched demonstrate that glycoside hydrolase families 27, 31, 36 and 66 share a common evolutionary origin with family 13 FEBS Lett. 523 2002 17 22
8. M.M. Hermans, M.A. Kroos, J.V. Beeumen, B.A. Oostra, and A.J. Reuser Human lysosomal α-glucosidase: characterisation of the catalytic site J. Biol. Chem. 266 1991 13507 13512
9. M. Okuyama, A. Okuno, N. Shimizu, H. Mori, A. Kimura, and S. Chiba Carboxyl group of residue Asp647 as possible proton donor in catalytic reaction of α-glucosidase from Schizosaccharomyces pombe Eur. J. Biochem. 268 2001 2270 2280
10. A.L. Lovering, S.S. Lee, Y. Kim, S.G. Withers, and N.C. Strynadka Mechanistic and structural analysis of a family 31 α-glycosidase and its glycosyl-enzyme intermediate J. Biol. Chem. 280 2005 2105 2115
11. D.A. Brooks, S. Fabrega, L.K. Hein, E.J. Parkinson, P. Durand, G. Yogalingam, U. Matte, R. Giugliani, A. Dasvarma, and J. Eslahpazire Glycosidase active site mutations in human α-l-iduronidase Glycobiology 11 2001 741 750
12. C.E. Nieman, A.W. Wong, S. He, L. Clarke, J.J. Hopwood, and S.G. Withers Family 39 α-l-iduronidases and β-d-xylosidases react through similar glycosyl-enzyme intermediates: identification of the human iduronidase nucleophile Biochemistry 42 2003 8054 8065
13. E.F. Neufeld, and J. Muenzer The Mucopolysaccharidosis C.R. Scriver A. Beaudet W.S. Sly D. Valle The Metabollic and Molecular Basis of Inherited Diseases 8th edn. 2001 McGraw-Hill New York 3421 3452
14. H.G. Hers Alpha-glucosidase deficiency in generalised glycogen-storage disease Biochem. J. 86 1963 11
15. Aldurazyme® product sheet 5649 (4/03). Genzyme Corporation, Cambridge, MA, USA.
16. J.E. Wraith, L.A. Clarke, M. Beck, E.H. Kolodny, G.M. Pastores, J. Muenzer, D.M. Rapoport, K.I. Berger, S.J. Swiedler, and E.D. Kakkis Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase) J. Pediatr. 144 2004 581 588
17. A. Amalfitano, A.R. Bengur, R.P. Morse, J.M. Majre, L.E. Case, D.L. Veerling, J. Mackey, P. Kishnanai, W. Smith, and A. McVie-Wylie Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial Genet. Med. 3 2001 132 138
18. P. Kishnani, T. Voit, M. Nicolino, C-H. Tsai, G. Herman, J. Waterson, A. Amalfitano, J. Charrow, G. Tiller, and B. Schaefer Enzyme replacement therapy for infantile onset Pompe disease: long term follow-up results Mol. Genet. Metab. 81 2004 169 (abstract)
19. J.M. Van den Hout, J.H. Kamphoven, L.P. Winkel, W.F. Arts, J.B. De Klerk, M.C. Loonen, A.G. Vulto, A. Cromme-Dijkhuis, N. Weisglas-Kuperus, and W. Hop Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk Pediatrics 113 2004 e448 e457
20. L.P. Winkel, J.M. Van den Hout, J.H. Kamphoven, J.A. Disseldorp, M. Remmerswaal, W.F. Arts, M.C. Loonen, A.G. Vulto, P.A. Van Doorn, and G. De Jong Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up Ann. Neurol. 55 2004 495 502
21. L. Klinge, V. Straub, U. Neudorf, J. Schaper, T. Bosbach, K. Gorlinger, M. Wallot, S. Richards, and T. Voit Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial Neuromuscul. Disord. 15 2005 24 31
22. E.J. Parkinson, V. Muller, J.J. Hopwood, and D.A. Brooks Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients Mol. Genet. Metab. 81 2004 58 64
23. R. Kakavanos, C.T. Turner, J.J. Hopwood, E.D. Kakkis, and D.A. Brooks Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I Lancet 361 2003 1608 1613
24. H.M. Geysen, R.H. Meloen, and S.J. Barteling Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid Proc. Natl. Acad. Sci. USA 81 1984 3998 4002
25. I. Callebaut, G. Labesse, P. Durand, A. Poupon, L. Canard, J. Chomilier, B. Henrissat, and J.P. Mornon Deciphering protein sequence information through hydrophobic cluster analysis (HCA): current status and perspectives Cell Mol. Life Sci. 53 1997 621 645
26. R.J. Moreland, X. Jin, X.K. Zhang, R.W. Decker, K.L. Albee, K.L. Lee, R.D. Cauthron, K. Brewer, T. Edmunds, and W.M. Canfield Lysosomal acid α-glucosidase consists of four different peptides processed from a single chain precursor J. Biol. Chem. 280 2005 6780 6791
27. E.N. Glaros, C.T. Turner, E.J. Parkinson, J.J. Hopwood, and D.A. Brooks Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation Mol. Genet. Metab. 77 2002 127 135
28. R.O. Brady, G.J. Murray, K.L. Oliver, S.F. Leitman, M.C. Sneller, T.A. Fleisher, and N.W. Barton Management of neutralising antibody to Ceredase in a patients with type 3 Gaucher disease Paediatrics 100 1997 127 135